ONUREG
Live / Registered — Registered (as of 04 Jan 2022)
What this means for you
Registered since 04 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90142491
- Registration number
- 6609412
- Mark type
- Design + words
- Filed
- 27 Aug 2020
- Published for opposition
- 10 Nov 2020
- Registered
- 04 Jan 2022
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use, namely, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for the treatment of blood disease and cancer
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 04 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Nov 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Oct 2021 — USE AMENDMENT FILED
- 25 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 03 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2021 — SOU EXTENSION 1 GRANTED
- 01 Jul 2021 — SOU EXTENSION 1 FILED
- 01 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 05 Jan 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Nov 2020 — PUBLISHED FOR OPPOSITION
- 21 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED